TAYLOR WESLEY: Open Payments
NPI 1598209512 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 73 payments from 21 companies in 2025. Trend: 2023 $1,497 · 2024 $2,502 · 2025 $1,303
Food & beverage: $1,287Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $201 |
| Novo Nordisk Inc | 13 | $182 |
| ABBVIE INC. | 16 | $170 |
| Abbott Laboratories | 7 | $162 |
| Amgen Inc. | 5 | $85 |
| Lundbeck LLC | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Lilly USA, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Viatris Specialty LLC | 2 | $38 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, VRAYLAR, REXULTI, Ozempic, Wegovy, BREZTRI, OTEZLA.
Industry payments across MO — which companies pay providers there.
